Role of chemokines in endocrine autoimmune diseases

Mario Rotondi, Luca Chiovato, Sergio Romagnani, Mario Serio, Paola Romagnani

Research output: Contribution to journalArticle

161 Citations (Scopus)

Abstract

Chemokines are a group of peptides of low molecular weight that induce the chemotaxis of different leukocyte subtypes. The major function of chemokines is the recruitment of leukocytes to inflammation sites, but they also play a role in tumoral growth, angiogenesis, and organ sclerosis. In the last few years, experimental evidence accumulated supporting the concept that interferon-γ (IFN-γ) inducible chemokines (CXCL9, CXCL10, and CXCL11) and their receptor, CXCR3, play an important role in the initial stage of autoimmune disorders involving endocrine glands. The fact that, after IFN-γ stimulation, endocrine epithelial cells secrete CXCL10, which in turn recruits type 1 T helper lymphocytes expressing CXCR3 and secreting IFN-γ, thus perpetuating autoimmune inflammation, strongly supports the concept that chemokines play an important role in endocrine autoimmunity. This article reviews the recent literature including basic science, animal models, and clinical studies, regarding the role of these chemokines in autoimmune endocrine diseases. The potential clinical applications of assaying the serum levels of CXCL10 and the value of such measurements are reviewed. Clinical studies addressing the issue of a role for serum CXCL10 measurement in Graves' disease, Graves' ophthalmopathy, chronic autoimmune thyroiditis, type 1 diabetes mellitus, and Addison's disease have been considered. The principal aim was to propose that chemokines, and in particular CXCL10, should no longer be considered as belonging exclusively to basic science, but rather should be used for providing new insights in the clinical management of patients with endocrine autoimmune diseases.

Original languageEnglish
Pages (from-to)492-520
Number of pages29
JournalEndocrine Reviews
Volume28
Issue number5
DOIs
Publication statusPublished - Aug 2007

Fingerprint

Endocrine System Diseases
Chemokines
Autoimmune Diseases
Interferons
Chemokine CXCL11
Chemokine CXCL9
CXCR3 Receptors
Leukocyte Chemotaxis
Chemokine CXCL10
Graves Ophthalmopathy
Inflammation
Endocrine Glands
Autoimmune Thyroiditis
Addison Disease
Endocrine Cells
Graves Disease
Sclerosis
Helper-Inducer T-Lymphocytes
Serum
Autoimmunity

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Role of chemokines in endocrine autoimmune diseases. / Rotondi, Mario; Chiovato, Luca; Romagnani, Sergio; Serio, Mario; Romagnani, Paola.

In: Endocrine Reviews, Vol. 28, No. 5, 08.2007, p. 492-520.

Research output: Contribution to journalArticle

Rotondi, Mario ; Chiovato, Luca ; Romagnani, Sergio ; Serio, Mario ; Romagnani, Paola. / Role of chemokines in endocrine autoimmune diseases. In: Endocrine Reviews. 2007 ; Vol. 28, No. 5. pp. 492-520.
@article{285b63f32e594ca185b05db0f7720339,
title = "Role of chemokines in endocrine autoimmune diseases",
abstract = "Chemokines are a group of peptides of low molecular weight that induce the chemotaxis of different leukocyte subtypes. The major function of chemokines is the recruitment of leukocytes to inflammation sites, but they also play a role in tumoral growth, angiogenesis, and organ sclerosis. In the last few years, experimental evidence accumulated supporting the concept that interferon-γ (IFN-γ) inducible chemokines (CXCL9, CXCL10, and CXCL11) and their receptor, CXCR3, play an important role in the initial stage of autoimmune disorders involving endocrine glands. The fact that, after IFN-γ stimulation, endocrine epithelial cells secrete CXCL10, which in turn recruits type 1 T helper lymphocytes expressing CXCR3 and secreting IFN-γ, thus perpetuating autoimmune inflammation, strongly supports the concept that chemokines play an important role in endocrine autoimmunity. This article reviews the recent literature including basic science, animal models, and clinical studies, regarding the role of these chemokines in autoimmune endocrine diseases. The potential clinical applications of assaying the serum levels of CXCL10 and the value of such measurements are reviewed. Clinical studies addressing the issue of a role for serum CXCL10 measurement in Graves' disease, Graves' ophthalmopathy, chronic autoimmune thyroiditis, type 1 diabetes mellitus, and Addison's disease have been considered. The principal aim was to propose that chemokines, and in particular CXCL10, should no longer be considered as belonging exclusively to basic science, but rather should be used for providing new insights in the clinical management of patients with endocrine autoimmune diseases.",
author = "Mario Rotondi and Luca Chiovato and Sergio Romagnani and Mario Serio and Paola Romagnani",
year = "2007",
month = "8",
doi = "10.1210/er.2006-0044",
language = "English",
volume = "28",
pages = "492--520",
journal = "Endocrine Reviews",
issn = "0163-769X",
publisher = "The Endocrine Society",
number = "5",

}

TY - JOUR

T1 - Role of chemokines in endocrine autoimmune diseases

AU - Rotondi, Mario

AU - Chiovato, Luca

AU - Romagnani, Sergio

AU - Serio, Mario

AU - Romagnani, Paola

PY - 2007/8

Y1 - 2007/8

N2 - Chemokines are a group of peptides of low molecular weight that induce the chemotaxis of different leukocyte subtypes. The major function of chemokines is the recruitment of leukocytes to inflammation sites, but they also play a role in tumoral growth, angiogenesis, and organ sclerosis. In the last few years, experimental evidence accumulated supporting the concept that interferon-γ (IFN-γ) inducible chemokines (CXCL9, CXCL10, and CXCL11) and their receptor, CXCR3, play an important role in the initial stage of autoimmune disorders involving endocrine glands. The fact that, after IFN-γ stimulation, endocrine epithelial cells secrete CXCL10, which in turn recruits type 1 T helper lymphocytes expressing CXCR3 and secreting IFN-γ, thus perpetuating autoimmune inflammation, strongly supports the concept that chemokines play an important role in endocrine autoimmunity. This article reviews the recent literature including basic science, animal models, and clinical studies, regarding the role of these chemokines in autoimmune endocrine diseases. The potential clinical applications of assaying the serum levels of CXCL10 and the value of such measurements are reviewed. Clinical studies addressing the issue of a role for serum CXCL10 measurement in Graves' disease, Graves' ophthalmopathy, chronic autoimmune thyroiditis, type 1 diabetes mellitus, and Addison's disease have been considered. The principal aim was to propose that chemokines, and in particular CXCL10, should no longer be considered as belonging exclusively to basic science, but rather should be used for providing new insights in the clinical management of patients with endocrine autoimmune diseases.

AB - Chemokines are a group of peptides of low molecular weight that induce the chemotaxis of different leukocyte subtypes. The major function of chemokines is the recruitment of leukocytes to inflammation sites, but they also play a role in tumoral growth, angiogenesis, and organ sclerosis. In the last few years, experimental evidence accumulated supporting the concept that interferon-γ (IFN-γ) inducible chemokines (CXCL9, CXCL10, and CXCL11) and their receptor, CXCR3, play an important role in the initial stage of autoimmune disorders involving endocrine glands. The fact that, after IFN-γ stimulation, endocrine epithelial cells secrete CXCL10, which in turn recruits type 1 T helper lymphocytes expressing CXCR3 and secreting IFN-γ, thus perpetuating autoimmune inflammation, strongly supports the concept that chemokines play an important role in endocrine autoimmunity. This article reviews the recent literature including basic science, animal models, and clinical studies, regarding the role of these chemokines in autoimmune endocrine diseases. The potential clinical applications of assaying the serum levels of CXCL10 and the value of such measurements are reviewed. Clinical studies addressing the issue of a role for serum CXCL10 measurement in Graves' disease, Graves' ophthalmopathy, chronic autoimmune thyroiditis, type 1 diabetes mellitus, and Addison's disease have been considered. The principal aim was to propose that chemokines, and in particular CXCL10, should no longer be considered as belonging exclusively to basic science, but rather should be used for providing new insights in the clinical management of patients with endocrine autoimmune diseases.

UR - http://www.scopus.com/inward/record.url?scp=34547805260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547805260&partnerID=8YFLogxK

U2 - 10.1210/er.2006-0044

DO - 10.1210/er.2006-0044

M3 - Article

C2 - 17475924

AN - SCOPUS:34547805260

VL - 28

SP - 492

EP - 520

JO - Endocrine Reviews

JF - Endocrine Reviews

SN - 0163-769X

IS - 5

ER -